Fierce Biotech Summit
Rebuilding: What’s Next for Biotech The biotech landscape is rapidly evolving, and with each breakthrough, the question arises: what’s next? Regulatory complexities, changing market dynamics and the need for sustained...
Rebuilding: What’s Next for Biotech The biotech landscape is rapidly evolving, and with each breakthrough, the question arises: what’s next? Regulatory complexities, changing market dynamics and the need for sustained...
The BIO Investor Forum Returns to San Francisco Focused on bringing together early-stage and established private biotech businesses with select investors, the BIO Investor Forum plays a vital role in...
The 12th Drug Discovery Strategic Summit (DDSS) is a purpose-built conference deliberately intended to address your concerns of corporate growth with a unique experience through an innovation-focused agenda, pre-scheduled meetings...
The system is everything from the early funding of new ideas by venture capitalists to treating patients to the administering of new medicines. In 2023, STAT will take a look...
We are excited to launch our Philadelphia CRADL® (Charles River Accelerator and Development Lab) facility to serve the local biotech and life science community. Register to secure your spot at our...